# Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

> **NCT04456140** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 230 (actual)

## Conditions studied

- Breast Carcinoma
- Digestive System Neoplasm
- Malignant Brain Neoplasm
- Malignant Central Nervous System Neoplasm
- Malignant Female Reproductive System Neoplasm
- Malignant Genitourinary System Neoplasm
- Malignant Head and Neck Neoplasm
- Malignant Musculoskeletal Neoplasm
- Malignant Solid Neoplasm
- Metastatic Malignant Neoplasm of Unknown Primary
- Skin Carcinoma

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Genetic Counseling
- **OTHER:** Genetic Testing
- **OTHER:** Survey Administration

## Key facts

- **NCT ID:** NCT04456140
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-29
- **Primary completion:** 2021-09-21
- **Final completion:** 2021-09-21
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2023-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04456140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04456140, "Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04456140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*